Immunogenicity of Salmonella typhi Ty21a vaccine for young children.

An attenuated Salmonella typhi Ty21a vaccine was administered to 18 infants and toddlers (less than or equal to 24 months old) to determine its safety and immunogenicity. The vaccination (10(9) CFU per dose, three doses) was well tolerated. However, after the vaccination there was no evidence of a h...

Description complète

Détails bibliographiques

Publié dans:	Infect Immun
Auteurs principaux:	Murphy, J R, Grez, L, Schlesinger, L, Ferreccio, C, Baqar, S, Muñoz, C, Wasserman, S S, Losonsky, G, Olson, J G, Levine, M M
Format:	Artigo
Langue:	Inglês
Publié:	American Society for Microbiology (ASM) 1991
Sujets:	Research Article
Accès en ligne:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC259034/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1937790/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/iai.59.11.4291-4293.1991
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!